GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: lapatinib ditosylate
Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: GlaxoSmithKline